• Version
  • Download 145
  • File Size 1.29 MB
  • File Count 1
  • Create Date January 23, 2020
  • Last Updated March 4, 2020

US Pharmaceutical Utilization Plateau

The 1990s are understandably thought of as a golden age in the U.S. pharmaceutical industry: the average number of new molecular entities approved each year was one-third higher than in the 2000s the majority of these drugs were in mass-market, primary care
segments that resulted in blockbuster sales; and marketing regulations, were substantially relaxed.

Attached Files

US Pharmaceutical Utilization Plateau.pdfDownload 
Scroll to Top